TLX 1.06% $18.14 telix pharmaceuticals limited

Ann: Telix Q1 2024 Revenue and Business Update, page-131

  1. 1,575 Posts.
    lightbulb Created with Sketch. 666
    CURRENT
    22 Feb 2024


    Full year 2024 outlook and guidanceTelix reaffirms guidance provided on 22 February 2024 for full year revenue expected to be in the range of US$445M to $465M (AU$675M to $705M at current exchange rates), representing an approximate 35-40% increase versus 2023.


    BUT
    17 April 2024

    U.S. revenue grew by 18% to US$111.8M (US$95.1M in Q4 2023), compared to 11% growth between Q3 2023 and Q4 2023.

    AND
    Guidance Note 8 on continuous disclosure requirements

    However, for the first time the ASX expressly stated that a listed entity should make an ASX announcement to update the market on its forecast earnings where it is different from consensus earnings forecasts by a specified percentage of 15%, even where the company has not issued any earnings guidance or forecast.
 
watchlist Created with Sketch. Add TLX (ASX) to my watchlist
(20min delay)
Last
$18.14
Change
0.190(1.06%)
Mkt cap ! $6.061B
Open High Low Value Volume
$17.98 $18.17 $17.67 $21.23M 1.181M

Buyers (Bids)

No. Vol. Price($)
1 2565 $18.10
 

Sellers (Offers)

Price($) Vol. No.
$18.14 1977 2
View Market Depth
Last trade - 16.10pm 20/06/2024 (20 minute delay) ?
TLX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.